Literature DB >> 19825923

Modelling mitigation strategies for pandemic (H1N1) 2009.

Marija Zivkovic Gojovic1, Beate Sander, David Fisman, Murray D Krahn, Chris T Bauch.   

Abstract

BACKGROUND: The 2009 influenza A (H1N1) pandemic has required decision-makers to act in the face of substantial uncertainties. Simulation models can be used to project the effectiveness of mitigation strategies, but the choice of the best scenario may change depending on model assumptions and uncertainties.
METHODS: We developed a simulation model of a pandemic (H1N1) 2009 outbreak in a structured population using demographic data from a medium-sized city in Ontario and epidemiologic influenza pandemic data. We projected the attack rate under different combinations of vaccination, school closure and antiviral drug strategies (with corresponding "trigger" conditions). To assess the impact of epidemiologic and program uncertainty, we used "combinatorial uncertainty analysis." This permitted us to identify the general features of public health response programs that resulted in the lowest attack rates.
RESULTS: Delays in vaccination of 30 days or more reduced the effectiveness of vaccination in lowering the attack rate. However, pre-existing immunity in 15% or more of the population kept the attack rates low, even if the whole population was not vaccinated or vaccination was delayed. School closure was effective in reducing the attack rate, especially if applied early in the outbreak, but this is not necessary if vaccine is available early or if pre-existing immunity is strong.
INTERPRETATION: Early action, especially rapid vaccine deployment, is disproportionately effective in reducing the attack rate. This finding is particularly important given the early appearance of pandemic (H1N1) 2009 in many schools in September 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825923      PMCID: PMC2774362          DOI: 10.1503/cmaj.091641

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  22 in total

1.  A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

Authors:  Trang Vu; Stephen Farish; Mark Jenkins; Heath Kelly
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

3.  Dynamical resonance can account for seasonality of influenza epidemics.

Authors:  Jonathan Dushoff; Joshua B Plotkin; Simon A Levin; David J D Earn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

4.  Strategies for containing an emerging influenza pandemic in Southeast Asia.

Authors:  Neil M Ferguson; Derek A T Cummings; Simon Cauchemez; Christophe Fraser; Steven Riley; Aronrag Meeyai; Sopon Iamsirithaworn; Donald S Burke
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

Review 5.  Herd protection against influenza.

Authors:  W Paul Glezen
Journal:  J Clin Virol       Date:  2006-09-26       Impact factor: 3.168

6.  Oral oseltamivir treatment of influenza in children.

Authors:  R J Whitley; F G Hayden; K S Reisinger; N Young; R Dutkowski; D Ipe; R G Mills; P Ward
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

7.  Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Authors:  J J Treanor; F G Hayden; P S Vrooman; R Barbarash; R Bettis; D Riff; S Singh; N Kinnersley; P Ward; R G Mills
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

8.  Containing pandemic influenza with antiviral agents.

Authors:  Ira M Longini; M Elizabeth Halloran; Azhar Nizam; Yang Yang
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

9.  Population-wide emergence of antiviral resistance during pandemic influenza.

Authors:  Seyed M Moghadas; Christopher S Bowman; Gergely Röst; Jianhong Wu
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

10.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069

View more
  49 in total

1.  An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus.

Authors:  Yasuko Hatta; Masato Hatta; Pamuk Bilsel; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

Review 2.  Economic evaluations of childhood influenza vaccination: a critical review.

Authors:  Anthony T Newall; Mark Jit; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

3.  Threshold dynamics in an SEIRS model with latency and temporary immunity.

Authors:  Yuan Yuan; Jacques Bélair
Journal:  J Math Biol       Date:  2013-08-29       Impact factor: 2.259

4.  Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.

Authors:  Elsa Hansen; Troy Day; Julien Arino; Jianhong Wu; Seyed M Moghadas
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

5.  Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

Authors:  Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman
Journal:  CMAJ       Date:  2009-12-03       Impact factor: 8.262

6.  Optimal pandemic influenza vaccine allocation strategies for the Canadian population.

Authors:  Ashleigh R Tuite; David N Fisman; Jeffrey C Kwong; Amy L Greer
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

7.  Pandemic dynamics and the breakdown of herd immunity.

Authors:  Guy Katriel; Lewi Stone
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

8.  Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.

Authors:  Eve Dubé; Vladimir Gilca; Chantal Sauvageau; Nicole Boulianne; François D Boucher; Julie A Bettinger; Shelly McNeil; Ian Gemmill; France Lavoie; Manale Ouakki
Journal:  BMC Res Notes       Date:  2010-04-14

9.  Optimizing vaccine allocation at different points in time during an epidemic.

Authors:  Laura Matrajt; Ira M Longini
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience.

Authors:  Beate Sander; Chris Bauch; David N Fisman; R Fowler; Jeffrey C Kwong; Allison McGeer; Marija Zivkovic Gojovic; Murray Krahn
Journal:  PLoS Curr       Date:  2009-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.